SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-024326
Filing Date
2023-07-12
Accepted
2023-07-12 16:00:32
Documents
18
Period of Report
2023-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 89798
2 ex4-1.htm EX-4.1 191908
3 ex4-2.htm EX-4.2 153137
4 ex4-3.htm EX-4.3 148308
5 ex10-1.htm EX-10.1 299965
6 ex10-2.htm EX-10.2 191433
7 ex10-4.htm EX-10.4 29608
  Complete submission text file 0001493152-23-024326.txt   1485980

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE mrzm-20230706.xsd EX-101.SCH 3015
9 XBRL LABEL FILE mrzm-20230706_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE mrzm-20230706_pre.xml EX-101.PRE 22359
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3025
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 231084220
SIC: 2834 Pharmaceutical Preparations